Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sermo (formerly known as WorldOne) is a leading global healthcare insights and physician engagement platform. Founded in 2000 as WorldOne, the company initially specialized in healthcare data collection and market research services. In 2012, WorldOne acquired Sermo, a prominent social network for doctors, and subsequently rebranded the entire organization under the Sermo name in 2014. The company now operates a massive digital ecosystem that connects over 1.3 million verified physicians across 150 countries, providing them with a platform for medical crowdsourcing and peer-to-peer collaboration. For pharmaceutical companies and healthcare agencies, Sermo offers high-fidelity market research, targeted promotional engagement, and real-world physician insights. Sermo was acquired by the private equity firm Abry Partners in 2022 to further accelerate its global growth and technology development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WorldOne.